secwatch.observer — SEC 8-K summary
======================================

Issuer:     MESA LABORATORIES INC /CO/ (MLAB)
CIK:        0000724004
Form:       8-K
Filed at:   2023-10-18T23:59:59+00:00
Accession:  0001437749-23-028494
Event type: m_and_a
Sentiment:  positive
Materiality: 0.70
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Mesa Labs completes acquisition of GKE for €85M; expects €19-20M revenue add
----------------------------------------------------------------------------

- Acquired GKE sterilization indicators business, SAL GmbH, and agreed to buy GKE China for €85M total.
- Financed with $65M from credit facility and $12.6M cash; GKE China close expected in Q3 FY2024.
- First 12 months of complete ownership expected to add €19-20M revenue with mid-single-digit organic growth.
- Adjusted operating income margin expected to approach 37%-40% for the first 12 months.
- Combined SDC division has over 200 distribution partners in 80+ countries.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/724004/000143774923028494/0001437749-23-028494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/724004/000143774923028494/mlab20231018_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-028494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer